Biocodex Inc

Open
Website
1850 Gateway Dr Ste 175
San Mateo, CA 94404
https://www.biocodex.us

Biocodex is a multinational pharmaceutical company that has been committed to healthcare with passion and conviction for over 60 years. With 16 subsidiaries and more than 100 partners, Biocodex has evolved from a French pioneer to an international player in the realm of gut microbiota, specializing in probiotic yeast strains and neurology products.

Under the leadership of CEO Nicolas COUDURIER, Biocodex has grown while remaining agile, capitalizing on their values and expanding their expertise in the microbiota field. With 1664 employees worldwide and a revenue of $501 million projected for 2022, Biocodex continues to prioritize healthcare innovation and development.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Drugs and drug proprietaries

Mirum Pharmaceuticals, Inc

Mirum Pharmaceuticals, Inc, based in Foster City, CA, is a biopharmaceutical company dedicated to developing transformative therapies for rare liver diseases. Their focus on addressing unmet needs in the community drives their passion for developing medicines with the potential to change lives. With a commitment to scientific discovery and evidence-based research, Mirum Pharmaceuticals is at the forefront of developing therapies that have the potential to revolutionize the treatment of rare liver diseases for generations to come. Their name, meaning "remarkable" in Latin, reflects their dedication to providing remarkable solutions for patients and their families. Generated from the website

Asegua Therapeutics LLC

Asegua Therapeutics LLC, located in Foster City, California, is an affiliate of Gilead Sciences Inc., specializing in providing therapies for patients. The company is committed to delivering high-quality medical information and resources intended to enhance patient care. Dedicated to the educational needs of U.S. residents, Asegua Therapeutics emphasizes the importance of discussing health-related matters with healthcare providers. Their trademarks, including ASEGUA and the ASEGUA logo, reflect their commitment to innovative therapeutic solutions. Generated from the website
ChemoCentryx, Inc

ChemoCentryx, Inc

Founded in 1997, ChemoCentryx is a clinical-based pharmaceutical company that discovers and develops orally-administered small molecule therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. It has developed EnabaLink, which is a drug recovery technology that is designed to accelerate productive drug recovery program. The company also conducts preclinical evaluation of a series of anticancer compounds that target the CXCR7 chemokine receptor. ChemoCentryx evaluates a series of compounds that target the C5a chemo-attractant receptor to treat age-related macular degeneration, rheumatoid arthritis and systemic lupus erythematosus and other disorders. It has entered into a strategic alliance with Glaxo Group, which is an affiliate of GlaxoSmithKline. ChemoCentryx maintains its headquarters in Mountain View, Calif.
United States›California›San Mateo›Biocodex Inc

Partial Data by Infogroup (c) 2024. All rights reserved.